Skip to main content

Advertisement

Table 1 The clinical profiles and tumor characteristics of 7 HCC patients with PVT and another 7 patients without PVT

From: Down-regulation of metabolic proteins in hepatocellular carcinoma with portal vein thrombosis

  PVT (n = 7) No PTV (n = 7) p
Gender (M/F) 7/0 5/2 0.462
Age [median(range)] 47 (39–71) 69 (53–79) 0.016
Operation    
 Lobectomy 4 0 0.070
 Segmentectomy 3 7  
Tumor    
 Size [median(range)] (cm) 8 (5–13) 4 (3.5–4.8) <0.001
 Vascular invasion (+/−) 7/0 0/7 <0.001
 Encapsulation (+/−) 3/4 7/0 0.070
 Daughter nodule (+/−) 4/3 1/6 0.266
 Diffentiation grade    
  1 0 0 0.229
  2 2 5  
  3 4 2  
  4 1 0  
Hepatitis    
 B (−)C (−) 2 1 0.801
 B (+)C (−) 4 5  
 B (−)C (+) 1 1  
 B (+)C (+) 0 0  
Cirrhosis (+/−) 6/1 5/2 1.000
AFP [median(range)] (ng/mL) 11.4 (2–1937) 11.0 (4.6–9198) 1.000
Survival [median(range)] (months) 4 (2.5–47) 53 (33–85) 0.002
  1. PVT portal vein thrombosis, AFP α-fetal protein